You discuss bupropion as a possible treatment for low sexual desire. In a patient complaining of low sexual desire who is currently otherwise successfully responding to an alternative antidepressant for a mood disorder, such as a selective serotonin reuptake inhibitor (SSRI), do you recommend changing to bupropion? How do you conduct the change in medication and what type of follow-up do you recommend? You discuss cognitive-behavioral therapy and sex therapy as interventions that may be useful in management of patients with low sexual desire. As a general gynecologist, I often find myself at a loss as to how to refer these patients, and I appreciate the referral resources you listed for sex therapists. Can you recommend referral resources for finding cognitive-behavioral therapists trained and experienced in the management of sexual dysfunction? How do you counsel patients with regard to what they can expect when seeing a sex therapist?
First, it is important to establish that the low desire is likely tied to the SSRI. This would necessitate a discussion with the patient to establish a temporal link with the onset of her low desire with the onset of the use of the SSRI.

If it is likely that the low desire is a side effect of the SSRI, it is fair to consider adding bupropion as
Response from Drs. Kingsberg and Woodard:
Testosterone as a treatment for hypoactive sexual desire seems to be somewhat controversial. You suggest that androgen levels are not helpful in diagnosis, but later you do note that free testosterone levels may be assessed during therapy to ensure they remain in the physiologic range for premenopausal women. At what point in assisting a patient with low sexual desire would you consider implementing testosterone therapy, and how do you counsel her? 
Response from Drs. Kingsberg and Woodard: Question 5:
How do you recommend counteracting low sexual desire caused by medically necessary drugs that the patient cannot discontinue, such as anticonvulsants or cardiovascular agents? For example, in a patient with a refractory seizure disorder who is well-controlled on carbamazepine and is advised not to try to change their anti-epileptic medication, how would you tailor your approach to their medication-related low sexual desire? Similarly, how would you recommend treating a patient with chronic heart disease who has been placed on long-term ACE inhibitor and/or digoxin therapy? Many patients are unable to take hormone replacement therapy for menopausal symptoms due to cardiovascular-or cancer-related risks, and their management can be challenging. In a patient who finds relief of her vasomotor symptoms with venlafaxine or paroxetine and who is unwilling to change medications, how do you recommend treating her low sexual desire?
Sometimes modest dose reductions in antidepressant medications used to treat vasomotor symptoms can help improve desire. One can also consider adding bupropion, which has been shown to be effective at reversing SSRI-induced sexual dysfunction in a small case series.
Response from Drs. Kingsberg and Woodard: Question 7:
In screening a couple with sexual problems, how do you coordinate care of the male partner for problems such as premature ejaculation or erectile dysfunction? 
